Recombinant Human GPR155 Protein (Baculovirus)，Strep & His

GPR155, a member of the G protein-coupled receptor (GPCR) family, has garnered attention in recent years due to its potential implications in neurological disorders and other pathophysiological conditions. It is predominantly expressed in the brain, particularly in regions associated with cognitive functions and motor control, suggesting a role in the modulation of neuronal signaling. Research indicates that GPR155 may participate in the regulation of the dopaminergic system, making it a candidate for studies related to neuropsychiatric diseases such as schizophrenia and depression. Furthermore, its unique structural features and expression patterns highlight its potential as a therapeutic target. Recent advancements in recombinant protein expression techniques have enabled the production of GPR155, facilitating detailed investigations into its receptor-ligand interactions, signaling pathways, and functional assays. Understanding the functional biology of GPR155 at the molecular level could provide insights into its role in health and disease, paving the way for novel therapeutic strategies that leverage its signaling mechanisms. As research progresses, GPR155 stands out as an intriguing target for drug discovery, particularly in the context of treating conditions linked to dysfunctional neurotransmission and neurodegeneration.